QUANTIFICATION OF APOLIPOPROTEIN A-IV IN HUMAN PLASMA BY IMMUNONEPHELOMETRY

被引:0
|
作者
SCHWARZ, S
HAAS, B
LULEY, C
SCHAFER, JR
STEINMETZ, A
机构
[1] UNIV MARBURG,ZENTRUM INNERE MED,ENDOKRINOL & STOFFWECHSEL ABT,D-35033 MARBURG,GERMANY
[2] UNIV FREIBURG,KLIN CHEM ABT,D-79106 FREIBURG,GERMANY
关键词
LIPOPROTEINS; ATHEROSCLEROSIS; ELECTROIMMUNODIFFUSION COMPARED; TRIGLYCERIDES; SAMPLE HANDLING;
D O I
暂无
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
We developed a nephelometric procedure for determining concentrations of human plasma apolipoprotein (ape) A-IV. Results obtained correlate well with those measured by an established electroimmunodiffusion assay (r = 0.98; n = 56). Intra- and interassay CVs were 2.4% and 2.0%, respectively, indicating excellent precision and reproducibility. Various conditions of sample treatment, such as adequate storage, freezing, and thawing, did not affect results significantly. However, keeping samples at room temperature for 4 days led to a slight increase in measured values. Preincubation with a cholesterinesterase-detergent mixture abolished interference from triglyceride-rich lipoproteins, allowing assay of samples containing triglycerides as great as 10 g/L. The assay is easily applicable to clinical laboratories for routine diagnostic use, as shown with hypertriglyceridemic plasmas and samples with a broad range of apo A-IV concentrations.
引用
收藏
页码:1717 / 1721
页数:5
相关论文
共 50 条
  • [31] Decreased plasma apolipoprotein A-IV levels in patients with acute coronary syndrome
    Li, Jiabei
    Song, Mingbao
    Qian, Dehui
    Lu, Wei
    Wang, Juan
    Jiang, Guoyan
    Jin, Jun
    Wu, Xiaojing
    Huang, Lan
    CLINICAL AND INVESTIGATIVE MEDICINE, 2013, 36 (04): : E207 - E215
  • [32] Low apolipoprotein A-IV plasma concentrations in men with coronary artery disease
    Kronenberg, F
    Stühlinger, M
    Trenkwalder, E
    Geethanjali, FS
    Pachinger, O
    von Eckardstein, A
    Dieplinger, H
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2000, 36 (03) : 751 - 757
  • [33] Plaque stabilizing effects of apolipoprotein A-IV
    Geronimo, F. R. B.
    Barter, P. J.
    Rye, K. A.
    Heather, A. K.
    Shearston, K. D.
    Rodgers, K. J.
    ATHEROSCLEROSIS, 2016, 251 : 39 - 46
  • [34] The relationship between plasma apolipoprotein A-IV levels and coronary heart disease
    Warner, MM
    Guo, JX
    Zhao, YM
    CHINESE MEDICAL JOURNAL, 2001, 114 (03) : 275 - 279
  • [35] Antioxidative and antiatherosclerotic effects of human apolipoprotein A-IV in apolipoprotein E-deficient mice
    Ostos, MA
    Conconi, M
    Vergnes, L
    Baroukh, N
    Ribalta, J
    Girona, J
    Caillaud, JM
    Ochoa, A
    Zakin, MM
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2001, 21 (06) : 1023 - 1028
  • [36] Macrovascular disease is associated with increased plasma apolipoprotein A-IV levels in NIDDM
    Verges, BL
    Lagrost, L
    Vaillant, G
    Petit, JM
    Cohen, M
    Gambert, P
    Brun, JM
    DIABETES, 1997, 46 (01) : 125 - 132
  • [37] Apolipoprotein A-IV Associated Cardiac Amyloidosis
    Bois, Melanie C.
    Dasari, Surendra
    Theis, Jason D.
    Vrana, Julie
    Grogan, Martha
    Dispenzieri, Angela
    Kurtin, Paul J.
    Maleszewski, Joseph J.
    MODERN PATHOLOGY, 2016, 29 : 81A - 82A
  • [38] Apolipoprotein A-IV, food intake, and obesity
    Tso, P
    Liu, M
    PHYSIOLOGY & BEHAVIOR, 2004, 83 (04) : 631 - 643
  • [39] Regulation of intestinal apolipoprotein A-IV synthesis
    Tso, P
    Yao, L
    Zheng, S
    Ee, L
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 1998, 13 : S270 - S274
  • [40] Regulation of intestinal and hypothalamic apolipoprotein A-IV
    Liu, M
    Doi, T
    Tso, P
    EXPERIMENTAL BIOLOGY AND MEDICINE, 2003, 228 (10) : 1181 - 1189